ICCVAM-NICEATM/ECVAM Scientific Workshop
on Alternative Methods to Refine, Reduce and Replace the Mouse LD50 Assay For Botulinum Toxin Testing
November 13-14, 2006 — Silver Spring, Maryland
Workshop report (NIH Publication No. 08-6416)
In response to a test method nomination from the Humane Society of the United States (HSUS), ICCVAM, in collaboration with NICEATM and ECVAM, co-sponsored a Scientific Workshop on Alternative Methods to Refine, Reduce, and Replace the Mouse LD50 Assay for Botulinum Toxin Testing. The 116 attendees from 9 countries included scientists from government and academic institutions, regulatory agencies, and the animal protection community.
In general, the consensus of workshop participants was that the reviewed methods could be used, in specific circumstances or in a tiered-testing strategy, to reduce or refine the use of mice in the current botulinum toxin test method. However, none of the reviewed methods could currently be used as a complete replacement for the current botulinum toxin test method. Participants noted that with additional development and validation efforts, one or more of the reviewed methods might be useful as a replacement for the current botulinum toxin test methods in the future. It was noted that additional validation studies were needed for most methods (e.g., comparison of results to in vivo outcomes, validation of methods for the specific applications). Finally, some best practices discussed to decrease the number of animals tested for studies included (a) use of reference standards to minimize the number of replicate animals needed, (b) use of standardized methodology, and (c) reduction in the number of doses tested for assays where confirmation of potency is being evaluated.Read More
The goals of the workshop were:
Specific objectives of the workshop included:
In October 2005, the Humane Society of the United States (HSUS) submitted a test method nomination, "Alternative Methods to Replace the Mouse LD50 Assay for Botulinum Toxin Potency Testing." In the nomination, HSUS proposed a review of the validation status of available in vitro, ex vivo, and non-lethal in vivo test methods as potential replacements for the current botulinum toxin potency test method. The nomination also requested that ICCVAM work with partners and stakeholders to validate one or more of the alternative test methods available. The HSUS nomination was reviewed by both ICCVAM and SACATM in November to December 2005. Both committees endorsed the sponsorship of a workshop on alternative botulinum toxin test methods with high priority.